Forecast: Re-Import of Vaccines for Human Use to the UK

The forecasted re-import of vaccines for human use to the UK is set to increase progressively between 2024 and 2028. Starting from a value of 866.17 thousand USD in 2024, the expected values show a steady year-on-year increase through to 980.17 thousand USD in 2028. This indicates a Compound Annual Growth Rate (CAGR) over the projected period that demonstrates healthy growth in demand or need for re-imported vaccines. Given that the series does not provide 2023 data, exact past variations cannot be calculated.

Looking forward, watch for:

  • Potential impacts from global supply chain disruptions or advancements.
  • Changes in UK vaccine demand due to healthcare policy shifts.
  • Development and distribution of new vaccine technologies.
  • Geopolitical influences affecting trade and re-import needs.

Top Countries about Vaccine